Quantcast

Latest Sequenom Stories

2014-02-14 08:26:21

DUBLIN, Feb. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kkxpsb/molecular ) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and...

2014-02-13 08:30:15

SAN DIEGO, Feb. 13, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the fourth quarter and full year of 2013 after closing of the NASDAQ Global Market on Thursday, February 27, 2014. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at...

2014-02-05 16:26:28

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/r5d88l/molecular) has announced the addition of the "Concise Analysis of International Molecular Diagnostics in Genetic Testing" [http://www.researchandmarkets.com/research/r5d88l/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics in genetic testing brings advanced analytical techniques to...

2014-02-03 20:22:36

DUBLIN, February 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6cwsz6/molecular) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/6cwsz6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-16 16:24:23

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/322q6g/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/322q6g/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...

2014-01-09 16:25:35

SAN DIEGO, Jan, 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic...

2014-01-08 16:26:51

SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong. The patent claims novel methods for detecting fetal...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related